The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Cybin Inc. (CYBN) shows that investor sentiment remained same, with the stock’s consolidated last price remained same by $0.00, or -0.78%, to $0.32. The Cybin Inc. has recorded 74,516 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Cybin Announces Grant of U.S. Patent Covering Deuterated Tryptamines.
The company is listed on the AMEX and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $0.32 and fluctuated between $0.3200 as its day high and $0.3059 as its day low. The current market capitalization of Cybin Inc. is $98.67M. A total of 1.47 million shares were traded on the day, compared to an average of 2.67M shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, CYBN has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 4 BUYs and 0 SELLs from insiders. Insiders purchased 5,718,574 shares during that period but sold 0.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for CYBN in the last 3 months, the mean price target is $4.17 with high estimates of $10.00 and low estimates of $0.74. In terms of 52-week highs and lows, CYBN has a high of $1.03 and a low of $0.21.
As of this writing, CYBN has an earnings estimate of -$0.05 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.03 per share and a lower estimate of -$0.06. The company reported an EPS of -$0.07 in the last quarter, which was -40.00% lower than expectations of -$0.05.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CYBN’s latest balance sheet shows that the firm has $53.64M in Cash & Short Term Investments as of fiscal 2022. Its Book Value Per Share was $0.19, while its Total Shareholder’s Equity was $76.16M.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CYBN is Buy with a score of 4.83.